Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra 12:42:32 2024-03-28 pm EDT After market 04:59:56 pm
28.43 EUR +0.04% Intraday chart for Bayer AG 28.44 +0.05%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
EMEA Morning Briefing : Stocks May Ease After Record Highs DJ
News Highlights : Top Company News of the Day - Friday at 1 AM ET DJ
Bayer says 2024 sales of prostate cancer drug above $1 billion RE
Bayer, Trinity Agtech Team Up for Agricultural Carbon Monitoring, Measuring MT
Bayer: partnership with UK-based Trinity Agtech CF
German Equities Rise as Markets Await US Fed Rate Decision MT
Bayer: collaboration with Thermo Fisher in oncology CF
Bayer appoints new COO in pharmaceuticals division CF
Bayer?s Pharmaceutical Division Announces Executive Appointments CI
Bayer AG and Thermo Fisher Scientific Inc. Collaborate to Increase Patient Access to Precision Cancer Medicines CI
Bayer Reshapes Pharmaceutical Division Leadership to Fuel Growth DJ
Global markets live: Nvidia, Cisco, BAE Systems, Diageo, Boeing... Our Logo
Bayer plans to apply for approval of drug to treat menopausal symptoms DP
BAYER AG : JP Morgan sticks Neutral ZD
Dpa-AFX Overview: COMPANIES from 19.03.2024 - 15:15 DP
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing CI
Bayer Announces Positive Topline Results from Phase III Long-Term Study Oasis 3 Support Submits for Marketing Authorization for Bayer's Elinzanetant CI
Bayer: further positive results in menopause CF
Bayer's Elinzanetant Reduces Menopausal Symptoms in Late-stage Trial MT
Bayer Menopause Drug Meets Key Goal in Late-Stage Trial DJ
Bayer to seek approval for menopausal relief drug after third trial win RE
BAYER SAYS POSITIVE RESULTS FROM PHASE III STUDY OASIS 3 SUPPORT… RE
Global markets live: Adobe, Ulta Beauty, Intel, Walt Disney, McDonald's... Our Logo
Chemical industry sees first signs of recovery after crisis year DP
Fitch Cuts Bayer's Rating on Softer FY24 Guidance MT
Chart Bayer AG
More charts
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.5%). Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
28.43 EUR
Average target price
37.6 EUR
Spread / Average Target
+32.25%
Consensus
  1. Stock
  2. Equities
  3. Stock Bayer AG - Xetra
  4. News Bayer AG
  5. Bayer to Shift Drug Research Focus Away from Women's Health